Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Tissue Diagnostic Market Grown from 2024 to 2025?

In recent times, a rapid expansion has been observed in the size of the tissue diagnostic market. This market is forecasted to escalate from $5.77 billion in 2024 to $6.44 billion in 2025, growing at a compound annual growth rate (CAGR) of 11.5%. The market’s growth during the historical period can be ascribed to factors like the aging population, growing instances of cancer, advances in technology, heightened disease awareness, and efficiency in the pathology workflow.

What Growth Rate Is Anticipated for the Tissue Diagnostic Market in the Coming Years?

The market for tissue diagnostics is projected to experience a swift expansion in the coming years, with a prediction to reach $10.67 billion by 2029, growing at a compound annual growth rate (CAGR) of 13.5%. The acceleration during the predicted period can be linked to the growth in personalized medications, liquid biopsy developments, adoption of AI and machine learning, expansion of telepathology, and the use of less invasive methods. Major upcoming trends during this period include digital pathology, further development and implementation of AI, services in telepathology, multiplex staining and imaging along with the integration of genomic data.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6505&type=smp

Who Are the Leading Companies in the Tissue Diagnostic Market?

Major companies operating in the tissue diagnostic market include F. Hoffmann-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Agilent Technologies Inc., Merck KGaA, BioGenex Laboratories, Sakura Finetek Co. Ltd., Philips Healthcare NV, Bio-Rad Laboratories, Ventana Medical Systems Inc., Hologic Inc., Becton Dickinson and Company, Sysmex Corporation, Cell Signaling Technology Inc., Enzo Life Sciences Inc., Epitomics Inc., Fluidigm Corporation, GE Healthcare Technologies Inc., Genomic Health Inc., Illumina Inc., Leica Microsystems GmbH, Menarini Diagnostics S.r.l, Myriad Genetics Inc., NanoString Technologies Inc., PerkinElmer Inc., QIAGEN N.V., Siemens Healthineers AG, Zeiss Group AG, CytomX Therapeutics Inc.

What Are the Key Drivers of the Tissue Diagnostic Market?

The escalation in cancer occurrences is set to stimulate the expansion of the tissue diagnostic market in the forthcoming years. The genesis of cancer is traced to genetic mutations causing wild cell growth which devastates body tissue and forms a mass known as a tumor. These tumors could either be cancerous or benign. A variety of causes, such as genetic mutations, carcinogens, smoking, obesity, radiation, hormones, etc., can contribute to cancer. The rising incidences of cancer necessitate diagnostic procedures like tissue diagnostics for disease determination. For example, the World Health Organization, a United Nations agency based out of Switzerland, predicted in February 2024 that there would be over 35 million new cancer cases by 2050, indicating a 77% increase from the projected 20 million cases in 2022. Hence, the surge in cancer prevalence underpins the growth of the tissue diagnostic market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=6505&type=smp

What Are the Key Market Segments in the Tissue Diagnostic Industry?

The tissue diagnostic market covered in this report is segmented –

1) By Product: Consumables, Antibodies, Kits, Reagents, Probes, Instruments, Slide Staining System, Scanner, Tissue Processing system

2) By Technology: Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology And Workflow Management, Special Staining

3) By Disease: Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer (NSCLC)

4) By End User: Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations

Subsegments:

1) By Consumables: Biopsy Needles, Slides And Cover Slips, Tissue Embedding Materials

2) By Antibodies: Primary Antibodies, Secondary Antibodies, Monoclonal Antibodies, Polyclonal Antibodies

3) By Kits: Diagnostic Kits, Assay Kits, Staining Kits

4) By Reagents: Fixatives, Staining Reagents, Antigen Retrieval Solutions

5) By Probes: Fluorescent Probes, Molecular Probes, Hybridization Probes

6) By Instruments: Microscopes, Tissue Microarray Instruments, Laser Capture Microdissection Instruments

7) By Slide Staining System: Automated Stainers, Manual Staining Systems

8) By Scanner: Digital Slide Scanners, Whole Slide Imaging Systems

9) By Tissue Processing System: Tissue Processors, Embedding Centers, Microtomes

What Are the Latest Trends in the Tissue Diagnostic Market?

The emergence of innovative product development is a major trend being observed in the tissue diagnostic market. This pertains to the development of groundbreaking products and solutions that have the capability to handle multiple samples, test them concurrently, automate lab procedures, and make these accessible to all. To stay competitive and boost income, leading players are concentrating on creating and supplying automated tissue diagnostic solutions. For example, Roche, a healthcare company based in Switzerland, unveiled the Benchmark ULTRA PLUS system for cancer diagnostics in June 2022. The BenchMark ULTRA PLUS tissue staining system, equipped with optimized workflow, effective testing features, and eco-friendly aspects, allows pathologists to deliver high-quality, time-sensitive results to physicians and patients. This newly released system is filled with several innovative attributes, such as user-friendly software, remote supervision capabilities, an integrated touchscreen for enhanced user interaction, and a more eco-friendly waste management and product packaging system.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/tissue-diagnostic-global-market-report

What Are the Key Regional Markets in the Tissue Diagnostic Industry?

North America was the largest region in the tissue diagnostic market in 2024. The regions covered in the tissue diagnostic market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6505

This Report Delivers Insight On:

1. How big is the tissue diagnostic market, and how is it changing globally?

2. Who are the major companies in the tissue diagnostic market, and how are they performing?

3. What are the key opportunities and risks in the tissue diagnostic market right now?

4. Which products or customer segments are growing the most in the tissue diagnostic market?

5. What factors are helping or slowing down the growth of the tissue diagnostic market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model